Seasons greetings! As the weather gets colder everyone gets busy. Your eyes have to last you a lifetime, so taking care of them is incredibly important. Your lifestyle can cause significant strain on your eye health and can have a harmful effect on your sight, especially as you grow older. Here are some Tips to take good care of your eye health…
Wouldn’t it be cool to have vampire eyes for Halloween? Or deep violet eyes to match your purple sweater? How about your favorite sports team’s logo on your eyes just for fun?
You can have all of these looks with decorative contact lenses (sometimes called “fashion,” “costume,” or “colored” contact lenses). These lenses don’t correct vision—they just change how your eyes look. But before buying decorative lenses, here’s what you should know. Read more
This day marks World Sight Day, and organizations from all corners of the optical industry around the world gather to make their voices count. World Sight Day (WSD) is an annual day of global awareness on blindness and vision impairment co-ordinated by IAPB under the VISION 2020 Global Initiative.
Based on a new global data report published by IAPB Vision Atlas, 253 million people are visually impaired while 89% of these people live in low- and middle-income countries. Moreover, localised and restricted environment in marginalized communities, such as ill-planned infrastructure and technological barriers, confers eye health challenges to children. Read more
It’s one of those awe-inspiring moments when Eyezone Magazine’s team finally bears witness to the unfolding of a promising future in optics. This dream is already reflected in “The Future of Optics” Convention where the Global ZEISS Vision Care community has met up in Berlin to try to offer the best vision possible – from the lens to virtualization, as well as, to digitized selling and all the science behind it. #ZEISSfuture is the hallmark of the convention, held in September of 2017. Read more
Drawing in over 8,000 UK and international visitors, one of the most talked about events, 100% Optical, is again on its way to give manufacturers, distributors, and suppliers a perfect platform to launch new products and increase brand awareness within the optical market. Running on its fifth year in 2018, the show’s growing exhibitor line-up includes some of the market leaders returning to the show, plus the famed catwalk flashing the hottest frame fashion styles and latest product innovations for 2018. Read more
Götti Switzerland introduces its new sales team member for the Middle East, Mr. Tarek Saoub. As sales representative for Gotti’s eyewear collections in the region, Mr. Saoub will showcase the new Götti Dimension Collection, the hyperprecise 3D printed glasses made in Switzerland. He will also launch Götti’s Perspective Collection, the reinvented, minimalist, and progressive rimless glasses. Gotti’s pure and linear design are fit for those who strive toward the style principle of reduction as its glasses embody authenticity in everyday life. Read more
July is UV Safety Month
UV radiation can damage your eyes as well as your skin. Studies suggest that overexposure to UV radiation can cause eye cataracts, eye damage, and suppression of the immune system, in general. May they be your family, friends, or colleagues – everyone is equally at risk for eye damage due to overexposure to the sun’s ultraviolet radiation.
The sun’s UV rays can burn the cornea of your eyes, which can result in cataracts that may ultimately cause blindness. Even short periods of exposure can lead to serious damage. Read more
Guest post by Sally Collins
The eyewear market in the Middle East is predicted to hit US$5.86 billion by 2023. The UAE leads the way, with the huge demand for luxury sunglasses being key to the UAE’s dominance. But sunglasses are much more than just a luxury fashion item. They are essential when it comes to protecting your vision. UV and blue light damage the retina’s pigment cells, which accelerates conditions like age-related macular degeneration (AMD). Yet, by wearing a quality pair of sunglasses, it’s possible to filter out these types of radiation. Furthermore, those suffering from AMD should wear protective sunglasses not only outdoors, but also sometimes indoors, too. Read more
Marcolin Group, a worldwide leading eyewear company, announced today to have signed a joint venture agreement with Rivoli Group, one of the largest luxury retailers in the Middle East area.
The JV, named Marcolin Middle East, is 51% owned by Marcolin Group and its headquarters will be based in Dubai in the United Arab Emirates. It will distribute the eyewear collections of the Marcolin’s brand portfolio: Tom Ford, Balenciaga, Ermenegildo Zegna, Montblanc, Roberto Cavalli, Tod’s, Emilio Pucci, Swarovski, Dsquared2, Diesel, Just Cavalli, Kenneth Cole, Timberland, Guess, Gant, Harley-Davidson, Marciano, Skechers and Web. Read more
Glaucoma affects at least one in every 25 people aged 40 years and above in Sub-Saharan Africa (SSA). It occurs as a result of the intraocular pressure (eye pressure [IOP]) being too high for the normal functioning of the optic nerve which is responsible for sight. Despite the vision loss that it causes, over half of the people with glaucoma are unaware and this is reflected in their late presentation in seeking care. A staggering 50% have already lost vision in one eye and are at high risk of losing vision in the second eye by the time they seek treatment.
There are three main modalities for treatment of glaucoma: medical, surgical or laser therapy. The choice of intervention currently depends on several factors related to the patient: stage/severity at presentation, compliance with health instruction, socio-economic status influencing ability to afford medicines and care, and residence in relation to follow-up. For example, the literate relative of a medical doctor may have medical therapy with 3-monthly follow-up; whereas for a rural non-schooled farmer, the better option may be a one-off surgical treatment (trabeculectomy) with follow-up in the local health centre.
The aim of treatment is to lower the IOP in order to prevent or slow down further vision loss, as any vision already lost cannot be restored. The prognosis when explained is often a source of anxiety to the newly diagnosed patients. Some patients do not accept their diagnosis nor comply with the treatment plan nor accept the prognosis. This leads them to seek multiple opinions in different hospitals, hopping and hoping.
Mrs CP is a 61-year old woman diagnosed with open-angle glaucoma:
“The vision impairment came in my adulthood. In fact, I did not know I had vision impairment, it came quite slowly. Now they say I have to use eye drops for the rest of my life. I cannot even find the drugs to buy and when I find they are so expensive, I cannot afford to buy. Even putting the eye drops is a problem as much of it runs down my face. And it stings.
My vision has worsened. I am tired. I have gone around so many eye clinics without any improvement. In fact, the teaching hospital is worst. I can hardly see and I was asked to go to so many points, pay so many times, wait for so long before I could see the specialist. And to think I have to do this for the rest of my life…Ah!!
I was already blind in one eye and the other eye is also going. Now they said I should have operation in my better eye… God forbid bad thing!! Let me just manage, when I have the money, I will buy the eye drops from the chemist.”
It is, therefore, imperative that we set our current priorities to:
1. Optimising treatment and patients’ care – i.e. doing the best for those who seek care.
2. Responding to patients’ perspectives with patients’ participation.
Strengthening clinical services would include training in surgical skills, laser procedures and building teams for optimal glaucoma care, for better treatment outcomes. Ensuring that effective medicines are available within well-equipped centres would also expand the treatment choices. Additionally, national guidelines and protocols would be helpful in optimising the diagnosis and treatment of patients.
Population-based surveys in SSA indicate that only about 10% of glaucoma patients seek hospital treatment. Additionally, there is a challenge in keeping patients within the health care system. To engage the patient, there should be counselling to enhance their understanding of the disease and encourage participation of the patient in their choice of therapy and compliance with treatment. The ease of financing mechanisms for their treatment is also important. Additional efforts should be geared towards providing a pleasant hospital experience so that a follow-up visit would entail a one-stop shop.
Eye care providers working together with patients with glaucoma will enhance better treatment outcomes in SSA and together they can be BIG; Beat Invisible Glaucoma.
The article above was written by Fatima Kyari, Consultant Ophthalmologist, IAPB West Africa Chair.